Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Emergent Biosolutions Inc. (EBS) had Debt to Capital Ratio of 0.55 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$222.20M |
|
$68.00M |
|
$88.50M |
|
$133.70M |
|
$172.30M |
|
$49.90M |
|
$42.80M |
|
$92.70M |
|
$92.70M |
|
$68.00M |
|
$68.00M |
|
$68.00M |
|
$68.00M |
|
$49.90M |
|
$77.60M |
|
54.40M |
|
57.30M |
|
$1.25 |
|
$1.19 |
|
| Balance Sheet Financials | |
$706.80M |
|
$221.00M |
|
$719.30M |
|
$1.43B |
|
$111.90M |
|
$665.70M |
|
$761.50M |
|
$873.40M |
|
$552.70M |
|
$67.50M |
|
$552.70M |
|
54.50M |
|
| Cash Flow Statement Financials | |
$-11.20M |
|
$59.50M |
|
$-0.40M |
|
$105.60M |
|
$152.80M |
|
$47.20M |
|
$1.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.32 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.55 |
1.20 |
|
60.17% |
|
22.46% |
|
22.46% |
|
-- |
|
41.72% |
|
30.60% |
|
$23.30M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.28 |
|
1.09 |
|
82.51 |
|
12.30% |
|
100.74% |
|
4.77% |
|
5.58% |
|
$10.14 |
|
$0.41 |
|
$-0.20 |
|